Colorado Biofactory, Inc. – Trademark Portfolio
Entity Type: 03
Colorado Biofactory, Inc. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 5 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 1 trademark is registered and 3 are pending. Notable registered marks include THATCHZYME. The owner is based in Colorado Springs, CO.
310 South 25th Street
Colorado Springs, CO 80904
Showing of trademarks Trademarks
Trademark Classifications
Colorado Biofactory, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific and technological services; industrial analysis and research services
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Colorado Biofactory, Inc. have?
Colorado Biofactory, Inc. has 5 U.S. trademarks filed with the USPTO. Of these, 1 registered, 3 pending, 1 abandoned.
What trademark classes does Colorado Biofactory, Inc. file in?
Colorado Biofactory, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 42 (Computer & Scientific), Class 5 (Pharmaceuticals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are Colorado Biofactory, Inc.'s most well-known trademarks?
Colorado Biofactory, Inc.'s registered trademark portfolio includes well-known marks such as THATCHZYME. These are among 1 currently registered trademark in the portfolio.
What is Colorado Biofactory, Inc.'s trademark registration success rate?
Colorado Biofactory, Inc. has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 3 applications are pending review.